Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 866 | 963 | 946 | 1069 | 1158 | 1678 |
Fund Return | -13.37% | -3.72% | -5.36% | 2.24% | 2.97% | 5.31% |
Place in category | 69 | 545 | 36 | 458 | 225 | 464 |
% in Category | 5 | 23 | 3 | 23 | 17 | 55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI C | 6.51B | 8.31 | 3.85 | 6.39 | ||
Acatis Gane Value Event Fonds UI A | 6.51B | 7.36 | 2.86 | 6.58 | ||
Acatis Gane Value Event Fonds UI B | 6.51B | 7.74 | 3.29 | 7.02 | ||
ACATIS Datini Valueflex Fonds A | 732.11M | 5.25 | -5.09 | 11.38 | ||
ACATIS Datini Valueflex Fonds B | 732.11M | 4.51 | -5.90 | 10.55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AriDeka CF | 2.88B | -18.81 | 1.20 | 5.15 | ||
Wellington Strategic European EquiS | 3.27B | 6.69 | 12.57 | 9.73 | ||
Wellington Strategic European EquNE | 3.27B | 2.44 | 11.69 | 9.65 | ||
Wellington Strategic European EquiD | 3.27B | 2.38 | 10.85 | 8.83 | ||
Industria P EUR | 22.48M | 4.52 | 3.09 | 6.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 7.13 | 78.74 | +1.31% | |
ASML Holding | NL0010273215 | 5.18 | 671.60 | +6.99% | |
Roche Holding Participation | CH0012032048 | 4.94 | 261.60 | -0.57% | |
Novartis | CH0012005267 | 4.55 | 92.73 | +0.85% | |
Novo Nordisk A/S Class B | DK0060534915 | 4.12 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review